drug

(drospirenone + estetrol)

Marketedupdated 2mo ago

by Mayne Pharma USA Inc

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

ClinicalTrials.gov

last refreshed 1h ago

Found something off?

Patent cliff

source: FDA Orange Book

first barrier falls

Jan 15, 2028

~1.5 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (7)

Oct 1, 2043method-of-use (U-3152)US 12458649
Feb 9, 2043formulationUS 12233074
Jun 17, 2036formulationUS 11793760
Jun 17, 2036formulationUS 11957694
Jun 17, 2036formulationUS 11964055
Jun 17, 2036formulationUS 12427114
Jan 15, 2028formulationUS 77324301.5y

FDA exclusivities (1)

Apr 15, 2026NCENew Chemical Entity (5y)